C. Ehmann

发表

Control of advanced and refractory acute myelogenous leukaemia with sirolimus‐based non‐myeloablative allogeneic stem cell transplantation

W. Rybka, D. Claxton, C. Ehmann, 2005, British journal of haematology.

Phase 1–2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B‐cell non‐Hodgkin lymphoma and previously untreated mantle cell lymphoma

M. Mori, E. Epner, Yiyi Chen, 2019, British journal of haematology.

Stem Cell Transplantation Therapy-induced Acute Lymphocytic Leukemia with the 11q23 Translocation: 2 Cases and a Review of the Literature

Monica Joshi, J. Drabick, H. Harvey, 2014 .

BU and CY as conditioning regimen for autologous transplant in patients with multiple myeloma

J. Drabick, W. Rybka, D. Claxton, 2009, Bone Marrow Transplantation.

Low-dose total body irradiation promotes T-cells donor chimerism in reduced-intensity/non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide

V. Brown, S. Mineishi, Shouhao Zhou, 2022, Leukemia Research.

Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis

V. Brown, S. Mineishi, H. Shike, 2022, Annals of Hematology.

Unexpected Short-Tandem-Repeat Patterns in Posttransplant Chimerism Testing: Investigation of 3 Cases with Help from Forensic Science.

S. Mineishi, H. Shike, W. Rybka, 2020, Laboratory medicine.

Sirolimus and tacrolimus allow engraftment of haploidentical and other alternative donor stem cells after non-myeloablative conditioning

F. Chiafari, W. Rybka, D. Claxton, 2004 .

Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion

V. Brown, S. Mineishi, B. Wirk, 2021, Annals of Hematology.